Last updated on December 2017

A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy and Safety of Zolmitriptan Nasal Spray for the Treatment of Acute Migraine in Subjects Ages 6 to 11 Years, with an Open-Label Extension.

Brief description of study

Protocol:  IPX229-B16-01
This is a study to evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years.

Clinical Study Identifier: TX154841

Find a site near you

Start Over

Texas Neurology, PA

6301 Gaston Avenue #100W Dallas, TX USA
  Connect »